Ten-year trends in antibiotic usage at a tertiary care hospital in Korea, 2004 to 2013
2
조회
0
다운로드
4
인용
0
참고문헌
키워드
초록
Background/Aims: This study was performed to evaluate trends in antibiotic usage at a tertiary care hospital in Korea. Methods: This study collated antibiotic prescription data and total patient days for inpatients at a tertiary care hospital in Korea between 2004 and 2013. The consumption of each class of antibiotic was converted to defined daily dose (DDD)/1,000 patient-days. We defined 3rd generation cephalosporins, 4th generation cephalosporins, β-lactam/β-lactamase inhibitors, and fluoroquinolones as broad-spectrum antibiotics; carbapenems, tigecycline, glycopeptides, oxazolidinone, and polymyxin were defined as antibiotics against multidrug-resistant (MDR) pathogens. Other antibiotic classes were defined as nonbroad-spectrum antibiotics. Results: Mean antibiotic consumption was 920.69 DDD/1,000 patient-days. The proportions of broad-spectrum antibiotics, antibiotics against MDR pathogens, and nonbroad-spectrum antibiotics were 41.8% (384.48/920.69), 3.5% (32.24/920.69), and 54.7% (503.97/920.69), respectively. Consumption of broad-spectrum antibiotics (coefficient for time 0.141; p = 0.049) and antibiotics against MDR pathogens (coefficient for time 0.185; p < 0.001) showed a significant increasing trend over the study period. Nonbroad-spectrum antibiotic consumption showed a significant decreasing trend over the study period (coefficient for time –2.601; p < 0.001). Conclusions: Over the 10-year period, a stepwise increase in the consumption of broad-spectrum antibiotics and antibiotics against MDR pathogens was observed at a tertiary care hospital in Korea. Conversely, during the same period, nonbroad- spectrum antibiotic consumption showed a significant decreasing trend.
Abstract
Background/Aims: This study was performed to evaluate trends in antibiotic usage at a tertiary care hospital in Korea. Methods: This study collated antibiotic prescription data and total patient days for inpatients at a tertiary care hospital in Korea between 2004 and 2013. The consumption of each class of antibiotic was converted to defined daily dose (DDD)/1,000 patient-days. We defined 3rd generation cephalosporins, 4th generation cephalosporins, β-lactam/β-lactamase inhibitors, and fluoroquinolones as broad-spectrum antibiotics; carbapenems, tigecycline, glycopeptides, oxazolidinone, and polymyxin were defined as antibiotics against multidrug-resistant (MDR) pathogens. Other antibiotic classes were defined as nonbroad-spectrum antibiotics. Results: Mean antibiotic consumption was 920.69 DDD/1,000 patient-days. The proportions of broad-spectrum antibiotics, antibiotics against MDR pathogens, and nonbroad-spectrum antibiotics were 41.8% (384.48/920.69), 3.5% (32.24/920.69), and 54.7% (503.97/920.69), respectively. Consumption of broad-spectrum antibiotics (coefficient for time 0.141; p = 0.049) and antibiotics against MDR pathogens (coefficient for time 0.185; p < 0.001) showed a significant increasing trend over the study period. Nonbroad-spectrum antibiotic consumption showed a significant decreasing trend over the study period (coefficient for time –2.601; p < 0.001). Conclusions: Over the 10-year period, a stepwise increase in the consumption of broad-spectrum antibiotics and antibiotics against MDR pathogens was observed at a tertiary care hospital in Korea. Conversely, during the same period, nonbroad- spectrum antibiotic consumption showed a significant decreasing trend.
참고문헌 (27)
- Spellberg B, "The epidemic of antibiotic-resistant infections: a call to action for the medical community from the Infectious Diseases Society of America", Clin Infect Dis, 46, pp.155~164 (2008)
- Kollef MH, "Broad-spectrum antimicrobials and the treatment of serious bacterial infections : getting it right up front", Clin Infect Dis, 47(Suppl 1), pp.S3~S13 (2008)
- David M. Livermore, "Current Epidemiology and Growing Resistance of Gram- Negative Pathogens", The Korean Journal of Internal Medicine, 27(2), pp.128~142 (2012), 대한내과학회[DOI]
- Angebault C, "Antimicrobial agent exposure and the emergence and spread of resistant microorganisms : issues associated with study design", Eur J Clin Microbiol Infect Dis, 32, pp.581~595 (2013)
- Dellit TH, "Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America guidelines for developing an institutional program to enhance antimicrobial stewardship", Clin Infect Dis, 44, pp.159~177 (2007)
- Ryu S, "The new Korean action plan for containment of antimicrobial resistance", J Glob Antimicrob Resist, 8, pp.70~73 (2017)
- "The core elements of hospital antibiotic stewardship programs" (2018)[URL]
- "Definition and general considerations" (2018)[URL]
- Clinical and Laboratory Standards Institute, "M100-S15Performance Standards for Antimicrobial Susceptibility Testing: Fifteenth Informational Supplement", CLSI, ~ (2005)
- 전강일, "일개 대학병원의 항생제 사용양상 변화(2001-2012)", 의료관련감염관리, 18(2), pp.44~50 (2013), 대한의료관련감염관리학회
- Song YA, "Relationship between antibiotic use and antibiotic resistance in major nosocomial pathogens at a university hospital", Chonnam Med J, 44, pp.137~143 (2008)
- Park J, "Antibiotic use in South Korea from 2007 to 2014 : a health insurance databasegenerated time series analysis", PLoS One, 12, pp.e0177435~ (2017)
- Yoon YK, "Trends of antibiotic consumption in Korea according to national reimbursement data (2008-2012): a population-based epidemiologic study", Medicine(Baltimore), 94, pp.e2100~ (2015)
- Mascarello M, "Correlation between antibiotic consumption and resistance of bloodstream bacteria in a University Hospital in North Eastern Italy, 2008-2014", Infection, 45, pp.459~467 (2017)
- Cooke J, "Longitudinal trends and cross-sectional analysis of English national hospital antibacterial use over 5 years (2008-13): working towards hospital prescribing quality measures", J Antimicrob Chemother, 70, pp.279~285 (2015)
- "Summary of the latest data on antibiotic consumption in the European Union 2014" (2014)[URL]
- 김도균, "Increasing Resistance to Extended-Spectrum Cephalosporins, Fluoroquinolone, and Carbapenem in Gram-Negative Bacilli and the Emergence of Carbapenem Non-Susceptibility in Klebsiella pneumoniae: Analysis of Korean Antimicrobial Resistance Monitoring System (KARMS) Data From 2013 to 2015", Annals of Laboratory Medicine, 37(3), pp.231~239 (2017), 대한진단검사의학회
- Chang YT, "Epidemiology and trends in the antibiotic susceptibilities of Gram-negative bacilli isolated from patients with intra-abdominal infections in the Asia-Pacific region, 2010-2013", Int J Antimicrob Agents, 49, pp.734~739 (2017)
- Moon HW, "Antimicrobial susceptibility profiles of Staphylococcus aureus isolates classified according to their origin in a tertiary hospital in Korea", Am J Infect Control, 42, pp.1340~1342 (2014)
- American Thoracic Society, "Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcareassociated pneumonia", Am J Respir Crit Care Med, 171, pp.388~416 (2005)
- Mandell LA, "Infectious Diseases Society of America", American Thoracic Society consensus guidelines on the management of communityacquired pneumonia in adults, 2007, pp.44(Suppl 2), S27~S72
- 송재훈, "지역사회획득 폐렴의 치료지침 권고안", Tuberculosis and Respiratory Diseases, 67(4), pp.281~302 (2009), 대한결핵및호흡기학회
- Wunderink RG, "Community-acquired pneumonia versus healthcare-associated pneumonia. The returning pendulum", Am J Respir Crit Care Med, 188, pp.896~898 (2013)
- Luyt CE, "Antibiotic stewardship in the intensive care unit", Crit Care, 18, pp.480~ (2014)
- Choi JY, "Trends in the distribution and antimicrobial susceptibility of causative pathogens of device-associated infection in Korean intensive care units from 2006 to 2013: results from the Korean Nosocomial Infections Surveillance System (KONIS)", J Hosp Infect, 92, pp.363~371 (2016)
- 김봉영, "A Survey of Antimicrobial Stewardship Programs in Korea, 2015", Journal of Korean Medical Science, 31(10), pp.1553~1559 (2016), 대한의학회
- Barlam TF, "Implementing an antibiotic stewardship program : guidelines by the Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America", Clin Infect Dis, 62, pp.e51~e77 (2016)